Repositioning of mitochondria-targeted FDA approved small molecules, and development and testing of
33/11/2023/RD/BMS
ICMR
None
None
Three Year
Mitochondrial Skeletal Disorders (MSDs)
None
None
None
Mitochondrial Skeletal Disorders (MSDs)
None
None
Dr Aarti Sevilimedu/None/Dr. Reddy's Institute of Life Sciences